CYSTEA-BONEEvaluation of Cysteamine Toxicity on Human Osteoclasts in Nephropathic Cystinosis Patients

Nephropathic Cystinosis (NC) is a rare, inherited disease that affects the body's ability to transport a specific protein, cystinosin. This leads to a build-up of a certain amino acid, cystine, in various organs. People with NC typically take a medication called cysteamine. Recently, it's been observed that bone issues can arise in adolescence or early adulthood for NC patients. The exact cause is still unclear, but it's thought to be linked to either the toxicity of cysteamine or the direct impact of the cystinosin mutation on bones. This study aims to deepen our understanding of bone disease in NC, which could significantly improve the quality of life for those affected. In this observational study, researchers will evaluate how cysteamine affects the bone cells of NC patients, specifically focusing on a type of cell called osteoclasts. These cells play a crucial role in bone health. The study will also examine the bone status of NC patients in relation to their specific genetic makeup. To measure the results, the study will count the number of a certain type of osteoclast cell, known as Tartrate-resistant acid phosphatase (TRAP) cells, at the end of the observation period.